FDA Inspection 1098877 — Vitalant Reference and Transfusion Service

Vitalant Reference and Transfusion Service — FEI 2570023

The FDA completed an inspection of Vitalant Reference and Transfusion Service on August 5, 2019 in Pittsburgh, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 5, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Pittsburgh, PA (United States)

Citations

IDCFRDescription
15021 CFR 606.151(e)Procedures to maintain records of emergency transfusions
16021 CFR 606.160(a)(1)Person performing, test results, interpretation